NanoViricides, Inc. (NNVC)
AMEX·Healthcare·Biotechnology
$1.23
-2.00%
Mkt Cap $17.51M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | — | — | — | -$0.14 | -$0.11 | +21.43% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.18 | -$0.10 | +44.44% | — | — |
| Q3 2025 Sep 29, 2025 | — | — | — | -$0.20 | -$0.13 | +35.00% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.19 | -$0.14 | +26.32% | — | — |
| Q1 2025 Feb 14, 2025 | — | — | — | -$0.18 | -$0.14 | +22.22% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.17 | -$0.23 | -35.29% | — | — |
| Q3 2024 Sep 27, 2024 | — | — | — | -$0.20 | -$0.19 | +5.00% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.19 | -$0.16 | +15.79% | — | — |
| Q1 2024 Feb 14, 2024 | — | — | — | -$0.19 | -$0.18 | +5.26% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.17 | -$0.17 | +0.00% | — | — |
| Q4 2023 Oct 13, 2023 | — | — | — | -$0.17 | -$0.31 | -82.35% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.17 | -$0.15 | +11.76% | — | — |
| Q1 2023 Feb 14, 2023 | — | — | — | -$0.16 | -$0.15 | +6.25% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.17 | -$0.14 | +17.65% | — | — |
| Q4 2022 Oct 13, 2022 | — | — | — | -$0.23 | -$0.15 | +34.78% | — | — |
| Q2 2022 May 17, 2022 | — | — | — | -$0.16 | -$0.16 | +0.00% | — | — |
| Q1 2022 Feb 14, 2022 | — | — | — | -$0.22 | -$0.17 | +22.73% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.20 | -$0.23 | -15.00% | — | — |
| Q4 2021 Oct 12, 2021 | — | — | — | — | -$0.18 | — | — | — |
| Q2 2021 May 14, 2021 | — | — | — | — | -$0.19 | — | — | — |